Clinical value of ultradeep HIV-1 genotyping and tropism testing in late presenters with advanced disease. -.- 26565

Casadellà M, Manzardo C, Noguera-Julian M, Ferrer E, Domingo P, Pérez-Álvarez S, Podzamczer D, Plana M, Clotet B, Gatell JM, Miró JM, Paredes R, ADVANZ and ADVANZ-3 Investigators.

Aids. 2015; 29: 1493-1504. FI: 5.554 (Q1).

Ehun ingeniaritza

Coffee and tea consumption and risk of pre- and postmenopausal breast cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort study. -.- 26026

Bhoo-Pathy N, Peeters PHM, Uiterwaal CSPM, Bueno-de-Mesquita HB, Bulgiba AM, Bech BH, Overvad K, Tjonneland A, Olsen A, Clavel-Chapelon F, Fagherazzi G, Perquier F, Teucher B, Kaaks R, Schuetze M, Boeing H, Lagiou P, Orfanos P, Trichopoulou A, Agnoli C, Mattiello A, Palli D, Tumino R, Sacerdote C, van Duijnhoven FJB, Braaten T, Lund E, Skeie G, Redondo ML, Buckland G, Sanchez MJ, Chirlaque MD, Ardanaz E, Amiano P, Wirfalt E, Wallstrom P, Johansson I, Nilsson LM, Khaw KT, Wareham N, Allen NE, Key TJ, Rinaldi S, Romieu I, Gallo V, Riboli E, van Gils CH.

Breast Cancer Res. 2015; 17. FI: 5.490 (Q1).

Gaixotasun kroniko eta transmitigarrien epidemiologia

Circulating prolactin and in situ breast cancer risk in the European EPIC cohort: a case-control study. -.- 26031

Tikk K, Sookthai D, Fortner RT, Johnson T, Rinaldi S, Romieu I, Tjonneland A, Olsen A, Overvad K, Clavel-Chapelon F, Baglietto L, Boeing H, Trichopoulou A, Lagiou P, Trichopoulos D, Masala G, Krogh V, Tumino R, Ricceri F, Mattiello A, Agudo A, Menendez V, Sanchez MJ, Amiano P, Chirlaque MD, Barricarte A, Bueno-de-Mesquita HB, Monninkhof EM, Onland-Moret NC, Andresson A, Sund M, Weiderpass E, Khaw KT, Key TJ, Travis RC, Merritt MA, Riboli E, Dossus L, Kaaks R.

Breast Cancer Res. 2015; 17. FI: 5.490 (Q1).

Gaixotasun kroniko eta transmitigarrien epidemiologia

Genetic risk variants associated with in situ breast cancer. -.- 26116

Campa D, Barrdahl M, Gaudet MM, Black A, Chanock SJ, Diver WR, Gapstur SM, Haiman C, Hankinson S, Hazra A, Henderson B, Hoover RN, Hunter DJ, Joshi AD, Kraft P, Le Marchand L, Lindstrom S, Willett W, Travis RC, Amiano P, Siddiq A, Trichopoulos D, Sund M, Tjonneland A, Weiderpass E, Peeters PH, Panico S, Dossus L, Ziegler RG, Canzian F, Kaaks R.

Breast Cancer Res. 2015; 17. FI: 5.490 (Q1).

Gaixotasun kroniko eta transmitigarrien epidemiologia

Reactivation of the inactive X chromosome and post-transcriptional reprogramming of Xist in iPSCs. -.- 26321

Kim JS, Choi HW, Arauzo-Bravo MJ, Schoeler HR, Do JT.

J. Cell Sci. 2015; 128: 81-87. FI: 5.432 (Q1).

Biologia Konputazionala eta Sistemen Biomedikuntza

Completeness and timeliness: Cancer registries could/should improve their performance. -.- 26081

Zanetti R, Schmidtmann I, Sacchetto L, Binder-Foucard F, Bordoni A, Coza D, Ferretti S, Galceran J, Gavin A, Larranaga N, Robinson D, Tryggvadottir L, Van Eycken E, Zadnik V, Coebergh JWW, Rosso S.

Eur. J. Cancer. 2015; 51: 1091-1098. FI: 5.417 (Q1).

Gaixotasun kroniko eta transmitigarrien epidemiologia

Survival of women with cancers of breast and genital organs in Europe 1999-2007: Results of the EUROCARE-5 study. -.- 26193

Sant M, Chirlaque MD, Agresti R, Sanchez Perez MJ, Holleczek B, Bielska-Lasota M, Dimitrova N, Innos K, Katalinic A, Langseth H, Larranaga N, Rossi S, Siesling S, Minicozzi P. EUROCARE 5 Working Grp.

Eur. J. Cancer. 2015; 51: 2191-2205. FI: 5.417 (Q1).

Gaixotasun kroniko eta transmitigarrien epidemiologia

Survival of male genital cancers (prostate, testis and penis) in Europe 1999-2007: Results from the EUROCARE-5 study. -.- 26198

Trama A, Foschi R, Larranaga N, Sant M, Fuentes-Raspall R, Serraino D, Tavilla A, Van Eycken L, Nicolai N. EUROCARE 5 Working Grp.

Eur. J. Cancer. 2015; 51: 2206-2216. FI: 5.417 (Q1).

Gaixotasun kroniko eta transmitigarrien epidemiologia

Distinct Neurodegenerative Changes in an Induced Pluripotent Stem Cell Model of Frontotemporal Dementia Linked to Mutant TAU Protein. -.- 26382

Ehrlich M, Hallmann AL, Reinhardt P, Arauzo-Bravo MJ, Korr S, Roepke A, Psathaki OE, Ehling P, Meuth SG, Oblak AL, Murrell JR, Ghetti B, Zaehres H, Schoeler HR, Sterneckert J, Kuhlmann T, Hargus G.

Stem Cell Rep. 2015; 5: 83-96. FI: 5.365 (Q1).

Biologia Konputazionala eta Sistemen Biomedikuntza

Fish consumption and mortality in the European Prospective Investigation into Cancer and Nutrition cohort. -.- 25949

Engeset D, Braaten T, Teucher B, Kuhn T, Bueno-de-Mesquita HB, Leenders M, Agudo A, Bergmann MM, Valanou E, Naska A, Trichopoulou A, Key TJ, Crowe FL, Overvad K, Sonestedt E, Mattiello A, Peeters PH, Wennberg M, Jansson JH, Boutron-Ruault MC, Dossus L, Dartois L, Li K, Barricarte A, Ward H, Riboli E, Agnoli Cl, Huerta JM, Sanchez MJ, Tumino R, Altzibar JM, Vineis P, Masala G, Ferrari P, Muller DC, Johansson M, Redondo ML, Tjonneland A, Olsen A, Olsen KS, Brustad M, Skeie G, Lund E.

Eur. J. Epidemiol. 2015; 30: 57-70. FI: 5.339 (Q1).

Gaixotasun kroniko eta transmitigarrien epidemiologia

Selective serotonin reuptake inhibitor antidepressant use in first trimester pregnancy and risk of specific congenital anomalies: a European register-based study. -.- 26289

Wemakor A, Casson K, Garne E, Bakker M, Addor MC, Arriola L, Gatt M, Khoshnood B, Klungsoyr K, Nelen V, O'Mahoney M, Pierini A, Rissmann A, Tucker D, Boyle B, de Jong-van den Berg L, Dolk H.

Eur. J. Epidemiol. 2015; 30: 1187-1198. FI: 5.339 (Q1).

Gaixotasun kroniko eta transmitigarrien epidemiologia

Diabetes mellitus and risk of c Investigation into Cancer and Nutrition. -.- 25843

Tsilidis KK, Allen NE, Appleby PN, Rohrmann S, Noethlings U, Arriola L, Gunter MJ, Chajes V, Rinaldi S, Romieu I, Murphy N, Riboli E, Tzoulaki I, Kaaks R, Lukanova A, Boeing H, Pischon T, Dahm CC, Overvad K, Quiros JR, Fonseca-Nunes A, Molina-Montes E, Gavrila D, Ardanaz E, Khaw KT, Wareham NJ, Roswall N, Tjonneland A, Lagiou P, Trichopoulos D, Trichopoulou A, Palli D, Pala V, Tumino R, Vineis P, Bueno-de-Mesquita HB, Malm J, Orho-Melander M, Johansson M, Stattin P, Travis RC, Key TJ.

Int. J. Cancer. 2015; 136: 372-381. FI: 5.085 (Q1).

Gaixotasun kroniko eta transmitigarrien epidemiologia

Endogenous androgens and risk of epithelial invasive ovarian cancer by tumor characteristics in the European Prospective Investigation into Cancer and Nutrition. -.- 25848

Ose J, Fortner RT, Rinaldi S, Schock H, Overvad K, Tjonneland A, Hansen L, Dossus L, Fournier A, Baglietto L, Romieu I, Kuhn E, Boeing H, Trichopoulou A, Lagiou P, Trichopoulos D, Palli D, Masala G, Sieri S, Tumino R, Sacerdote C, Mattiello A, Quiros JR, Obon-Santacana M, Larranaga N, Chirlaque MD, Sanchez MJ, Barricarte A, Peeters PH, Bueno-de-Mesquita HB, Onland-Moret NC, Braendstedt J, Lundin E, Idahl A, Weiderpass E, Gram IT, Lund E, Kaw KT, Travis RC, Merritt MA, Gunther MJ, Riboli E, Kaaks R.

Int. J. Cancer. 2015; 136: 399-410. FI: 5.085 (Q1).

Gaixotasun kroniko eta transmitigarrien epidemiologia

Variation at ABO histo-blood group and FUT loci and diffuse and intestinal gastric cancer risk in a European population. -.- 25858

Duell EJ, Bonet C, Munoz X, Lujan-Barroso L, Weiderpass E, Boutron-Ruault MC, Racine A, Severi G, Canzian F, Rizzato C, Boeing H, Overvad K, Tjonneland A, Argueelles M, Sanchez-Cantalejo E, Chamosa S, Huerta MJ, Barricarte A, Khaw KT, Wareham N, Travis RC, Trichopoulou A, Trichopoulos D, Yiannakouris N, Palli D, Agnoli C, Tumino R, Naccarati A, Panico S, Bueno-de-Mesquita HB, Siersema PD, Peeters PHM, Ohlsson B, Lindkvist B, Johansson I, Ye W, Johansson M, Fenger C, Riboli E, Sala N, Gonzalez CA.

Int. J. Cancer. 2015; 136: 880-893. FI: 5.085 (Q1).

Gaixotasun kroniko eta transmitigarrien epidemiologia